Exsitec Holding AB (OSTO:EXS)

Q3 2025 Exsitec Holding AB Earnings Call Transcript

Oct 23, 2025 / 08:00 AM GMT

Release Date Price: kr156 (+11.43%)

Transcript

Key Points

Positve

Exsitec Holding AB (FRA:1TI) reported an adjusted EBITA of 25 million SEK with a margin of 14%, a significant improvement from the previous year's 6 million SEK and 4% margin.
All segments reported organic growth, contributing to a 25% increase in recurring revenue from software, reaching 217 million SEK on an LTM basis.
Order intake increased by 10% compared to the same quarter last year, despite Q3 typically being the weakest period for new sales.
Net sales grew by 16% in Q3 compared to Q3 2024, with organic growth contributing 6%.
The company achieved a 25% year-on-year growth in recurring revenue from software, driven by M&A, new sales, and price increases.

Negative

Customers are cautious about investing further in their current solutions, a trend observed over the past 18 to 24 months.
The efficiency in Sweden and Norway can be improved, indicating room for operational enhancements.
The professional services segment faces challenges during the beginning of Q3, traditionally the most challenging period of the year.
M&A activity has not been favorable in 2025, with timing not being right for acquisitions.
The personal churn rate has remained stable, not showing significant improvement since the start of 2025.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

EXS.ST - Exsitec Holding AB
Q3 2025 Exsitec Holding AB Earnings Call
Oct 23, 2025 / 08:00AM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
So, let's dive into specifics for Q3. I will start off with the highlights and then leave the word to Carl Anoon, our CFO for the financial details.

So exciting in Q3, I am really pleased with the results, which demonstrate the stability of our business model.

We report an adjusted EBITA of 25 million sick with a margin of 14%. This is a real improvement compared to Q3 last year where we reported 6 million sick in adjusted EBITA and a 4% margin.

The improvement comes from all segments and we will get back to those details shortly.

I am also pleased that all segments report organic growth at the same time this quarter.

And the main driver for our strong result is our recurring revenue from

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.